ChemDraw taught chemists to draw on a computer. Its owner now wants experiments, collaborators and AI models to speak the same language - and the most revealing case begins with a hunt for old lab notes.
BioIVT says IDBS helped it deliver research data at least four weeks faster. The company’s bigger bet: better lab records can speed the journey from experiment to manufacturing - and give AI something trustworthy to work with.
The laboratory software veteran survived an IPO, a $123 million sale, a 12-year corporate hibernation and a private-equity rebirth. Its next experiment is harder: turning a sprawling enterprise stack into one usable thread from scientific idea to released product.
Benchling is a cloud platform built for biotech R&D - a single, biology-first system of record where scientists design experiments, track samples, manage molecular data, and collaborate. Founded in 2012 out of MIT, it has grown into the operating system for modern life science, used by hundreds of thousands of scientists at companies ranging from startups to the largest biopharma firms, and is now embedding AI agents and predictive models directly into the lab workflow.